TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Inter TOTAL CHOLESTEROL PHOTOMETRY 236 mg/dL < 200 55 40-60 HDL CHOLESTEROL DIRECT LDL CHOLESTEROL DIRECT PHOTOMETRY PHOTOMETRY < 100 TRIGLYCERIDES PHOTOMETRY mg/dL mg/dL mg/dL CALCULATED 167 56 4.3 Ratio < 150 3-5 TC/ HDL CHOLESTEROL RATIO TRIG /HDL RATIO CALCULATED 1.02 Ratio < 3.12 LDL / HDL RATIO CALCULATED Ratio 1.5-3.5 CALCULATED 3 0.33 Ratio > 0.40 CALCULATED 180.3 < 160 HDL / LDL RATIO NON-HDL CHOLESTEROL VLDL CHOLESTEROL CALCULATED 11.24 mg/dL mg/dL 5-40

Reading File
Finding Sources
Finding Sources
Searching PubMed

"LDL cholesterol" AND treatment guideline

Here's the lipid profile reconstructed and interpreted:
TestValueUnitsReference RangeFlag
Total Cholesterol236mg/dL< 200High
HDL Cholesterol (Direct)55mg/dL40-60Normal
LDL Cholesterol (Direct)167mg/dL< 100High
Triglycerides56mg/dL< 150Normal
TC/HDL Ratio4.3Ratio3-5Normal
TRIG/HDL Ratio1.02Ratio< 3.12Normal
LDL/HDL Ratio3.0Ratio1.5-3.5Normal
HDL/LDL Ratio0.33Ratio> 0.40Low (borderline)
Non-HDL Cholesterol180.3 (calc: 236-55=181)mg/dL< 160High
VLDL Cholesterol11.24mg/dL5-40Normal

Interpretation

Main abnormality: elevated LDL cholesterol (167 mg/dL) driving a high total cholesterol (236 mg/dL) and high non-HDL cholesterol (180 mg/dL). Triglycerides and VLDL are normal (and internally consistent: VLDL = Trig/5 = 56/5 = 11.2), and HDL sits at a reasonably good 55 mg/dL. This pattern - isolated LDL elevation with normal triglycerides/VLDL and adequate HDL - is a classic hypercholesterolemia (pure LDL-driven dyslipidemia) rather than a mixed or triglyceride-driven dyslipidemia.
  • LDL cholesterol is the primary target used to assess cardiac risk and guide lipid-lowering therapy - Henry's Clinical Diagnosis and Management by Laboratory Methods. At 167 mg/dL this is well above the desirable range and falls in the "high" category by most clinical classifications (borderline-high starts around 130, high at 160+, very high at 190+).
  • Non-HDL cholesterol (total cholesterol minus HDL) is elevated at ~180 mg/dL against a target of <160. This is a useful secondary target because it captures all atherogenic (apoB-containing) particles, including LDL and VLDL remnants.
  • The ratios (TC/HDL, LDL/HDL, TRIG/HDL) all fall within their reference bands, which reflects that HDL is not low and triglycerides are not elevated - the risk here is coming specifically from the absolute LDL burden, not an unfavorable ratio pattern.
  • HDL/LDL ratio of 0.33 is just under the >0.40 reference, reinforcing that LDL is disproportionately high relative to HDL, though this is a less commonly used clinical metric compared to LDL and non-HDL values directly.
Statin therapy is generally recommended when LDL is persistently elevated at this level, particularly if other cardiovascular risk factors (age, smoking, diabetes, hypertension, family history) are present - lowering LDL to below 100 mg/dL (or lower depending on overall cardiovascular risk category) is a standard treatment target - Goldman-Cecil Medicine. This is a lab snapshot, not a diagnosis; correlate with clinical risk factors, consider a repeat fasting sample, and have a clinician determine whether pharmacologic therapy (e.g., statin +/- ezetimibe) or lifestyle intervention alone is appropriate.
Recent evidence check: current meta-analyses continue to support LDL-lowering as the central strategy for reducing atherosclerotic cardiovascular risk, and increasingly support combination therapy (statin + ezetimibe or PCSK9 inhibitors) as an alternative to high-intensity statin monotherapy in higher-risk patients (Lee et al., JAMA Cardiology 2025, PMID: 39565634; Burnett et al., 2025, PMID: 40358978). These don't contradict the textbook interpretation above, just reinforce that non-statin add-on options are increasingly validated for patients who need additional LDL reduction.
If you can share the patient's age, sex, and any known cardiovascular risk factors (smoking, diabetes, hypertension, family history), I can help contextualize what LDL/treatment target would apply and whether lifestyle changes alone might suffice versus needing medication.
analyse_media
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources

Renal Function Panel - Interpretation

TestValueUnitsReference RangeFlag
Blood Urea Nitrogen (BUN)7.4mg/dL7.94-20.07Low
Creatinine - Serum0.41mg/dL0.55-1.02Low
BUN/Sr. Creatinine Ratio18.05Ratio9:1-23:1Normal
Urea (Calculated)15.84mg/dLAdult: 17-43Low
Urea/Sr. Creatinine Ratio38.62Ratio< 52Normal
Uric Acid3.18mg/dL3.2-6.1Borderline low (essentially at lower limit)
Calcium9.69mg/dL8.8-10.6Normal

What this means

This is a reassuring panel overall - there is no evidence of renal impairment. If anything, both nitrogenous waste markers (BUN/urea) and creatinine are mildly below their reference ranges, while the ratios between them remain normal (BUN:creatinine ~18:1, urea:creatinine ~39). That internal consistency matters clinically: renal dysfunction (especially prerenal azotemia from volume depletion or reduced perfusion) classically raises the BUN:creatinine ratio - Brenner and Rector's The Kidney. A proportionate, mild reduction in both values with a preserved normal ratio points away from kidney disease and toward one of several benign, non-renal explanations:
  • Low muscle mass - creatinine is generated from muscle metabolism, so individuals with lower muscle mass (commonly young adults, women, or lower body weight) - Fischer's Mastery of Surgery, Rheumatology 2-Volume Set
  • Low-protein or vegetarian diet / malnutrition - reduces the substrate for urea production - Frameworks for Internal Medicine, Fischer's Mastery of Surgery
  • Pregnancy - GFR increases and plasma volume expands, which lowers both BUN and creatinine as a normal physiological finding - Quick Compendium of Clinical Pathology
  • Overhydration / high fluid intake - dilutes both markers
  • Mild reduction in hepatic urea synthesis - since urea is made in the liver, though this is usually accompanied by other liver-related abnormalities - Basic Medical Biochemistry
Uric acid (3.18 mg/dL) sits right at the lower edge of the reference range (3.2-6.1) - this is not clinically meaningful and essentially reflects a normal value; true hypouricemia work-up would only be pursued if it were significantly below range or accompanied by symptoms.
Calcium (9.69 mg/dL) is comfortably within normal limits.

Bottom line

No signs of kidney dysfunction. The mildly low BUN, urea, and creatinine with preserved ratios most commonly reflect low muscle mass, diet, hydration status, or (if applicable) pregnancy rather than any pathological process. If this patient has unexplained fatigue, weight loss, or other symptoms of malnutrition or liver disease, that would be worth correlating clinically, but based on the numbers alone this panel does not suggest kidney disease. I don't have the patient's age, sex, body build, diet, or clinical context, so let me know if you'd like me to narrow the interpretation further.
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

"lipoprotein(a)" AND cardiovascular risk

Searching PubMed

"vitamin B12 deficiency" AND treatment

Searching the Web

Lipoprotein(a) 51 mg/dL cardiovascular risk interpretation 2025

Full "Outside Reference Range" Report - Consolidated Interpretation

CategoryTestValueUnitsRef. RangeFlag
Cardiac RiskLipoprotein(a) [Lp(a)]51mg/dL< 30High
CBCBasophils - Absolute0.01x10³/µL0.02-0.1Low
Lymphocytes40.9%20-40Mildly high
MCHC31.2g/dL31.5-34.5Mildly low
Monocytes - Absolute0.16x10³/µL0.2-1.0Low
Neutrophils - Absolute1.84x10³/µL2.0-7.0Low
Total WBC3.69x10³/µL4.0-10.0Low
UrineBloodPresent-AbsentAbnormal
ElectrolytesChloride107.6mmol/L98-107Mildly high
LipidLDL Cholesterol167mg/dL< 100High
Non-HDL Cholesterol180.3mg/dL< 160High
Total Cholesterol236mg/dL< 200High
HDL/LDL Ratio0.33Ratio> 0.40Low
RenalBUN, Creatinine, Urea, Uric Acid(as before)Low (benign pattern, discussed previously)
Vitamins25-OH Vitamin D16ng/mL30-100Deficient
Vitamin B12< 100pg/mL197-771Deficient

Interpretation by system

1. Cardiovascular risk - the most clinically significant cluster. Lp(a) at 51 mg/dL sits in the "high risk" category (levels ≥50 mg/dL / ≥125 nmol/L are classified as high risk by ESC/EAS, ACC/AHA, and NLA). Unlike LDL, Lp(a) is genetically determined, stable over a lifetime, and does not respond meaningfully to diet, exercise, or statins - so it is measured once to stratify risk rather than tracked serially. Combined with your already-elevated LDL (167) and non-HDL cholesterol (180), this patient has two independent, additive atherogenic risk factors - Fuster and Hurst's The Heart. Current evidence confirms Lp(a) contributes to cardiovascular risk independently of LDL-mediated risk (Bhatia et al. 2025, PMID 39492722), and risk rises continuously with higher Lp(a), without a plateau (per current epidemiological data). This combination usually prompts more aggressive LDL-lowering targets and closer cardiology follow-up, since no approved therapy yet directly lowers Lp(a) (RNA-targeting drugs like pelacarsen and lepodisiran are still in trials).
2. Mild pan-leukopenia (low WBC, neutrophils, monocytes, basophils) with relative lymphocytosis. Total WBC (3.69), absolute neutrophils (1.84), monocytes (0.16), and basophils (0.01) are all below range, while the lymphocyte percentage is push at the upper limit (40.9%). Important connective finding: vitamin B12 deficiency itself is a recognized cause of mild leukopenia (and sometimes thrombocytopenia) because B12 is required for DNA synthesis across all myeloid lineages, not just red cells - Katzung's Basic and Clinical Pharmacology. Given this patient's markedly low B12 (<100 pg/mL), the leukopenia pattern may well be a manifestation of the same underlying deficiency rather than a separate hematologic disease. That said, the absolute neutrophil count (1840/µL) does not meet the threshold for even mild neutropenia (ANC <1500) by standard emergency medicine criteria, so this is a soft, borderline finding rather than a dangerous one - Rosen's Emergency Medicine.
3. Urine blood present (hematuria). This always warrants follow-up rather than dismissal. Causes range from benign/transient (UTI, strenuous exercise, menstrual contamination) to more significant (kidney stones, glomerular disease, or, particularly in older patients, malignancy) - Campbell-Walsh Urology, Brenner and Rector's The Kidney. A repeat urinalysis plus microscopy (looking for red cell casts, dysmorphic RBCs, or crystals) and correlation with symptoms (flank pain, dysuria, recent exercise, menstrual cycle) is the appropriate next step; if it persists on a repeat sample, urology referral for further imaging/cystoscopy is standard practice, especially given the low-grade hematologic picture and unrelated renal findings.
4. Chloride mildly elevated (107.6, ref 98-107). This is only marginally above range and by itself is not concerning. Common benign causes include mild dehydration, high-chloride fluid or dietary intake, or lab variability. It becomes clinically relevant only if paired with a low bicarbonate/anion gap or acidosis, which isn't indicated here - Miller's Anesthesia, Tintinalli's Emergency Medicine.
5. Vitamin D deficiency (16 ng/mL, ref 30-100). This is a true deficiency (levels below 20 ng/mL are classified as deficient by the Endocrine Society), commonly linked to bone pain, muscle weakness, and impaired calcium handling, and is very common and easily correctable with supplementation - Endocrine Society Guideline (Dermatology 2-Volume Set); Harrison's Principles of Internal Medicine.
6. Vitamin B12 deficiency (<100 pg/mL, ref 197-771). This is a significant deficiency requiring treatment - classic causes include pernicious anemia (autoimmune, lack of intrinsic factor), vegan/vegetarian diet, prior gastrectomy or bariatric surgery, and malabsorption syndromes - Swanson's Family Medicine Review, Robbins & Kumar Basic Pathology. Left untreated, B12 deficiency can progress to megaloblastic anemia and, importantly, subacute combined degeneration of the spinal cord - an irreversible neurological complication if not corrected - Robbins & Kumar Basic Pathology, Guyton and Hall Physiology. Given this patient also has mild leukopenia, checking a complete blood count with peripheral smear (looking for macro-ovalocytes, hypersegmented neutrophils) and a methylmalonic acid/homocysteine level would help confirm the diagnosis and severity. Current systematic reviews show both oral high-dose and parenteral (IM) B12 replacement are effective, with parenteral typically preferred for severe or malabsorption-related deficiency (Abdelwahab et al. 2024, PMID 38231320; Sachdeva et al. 2025, PMID 39964959).

Bottom line / suggested next steps

  • Cardiology/lipid referral: elevated Lp(a) + elevated LDL/non-HDL cholesterol together represent a meaningfully increased ASCVD risk profile that should be discussed for statin intensification and closer risk-factor management.
  • Hematology correlation: repeat CBC with peripheral smear to see if the mild leukopenia resolves once B12 is repleted, and rule out other causes if it persists.
  • Urology follow-up: repeat urinalysis to confirm hematuria and pursue imaging/cystoscopy if it recurs.
  • Start Vitamin D and B12 replacement, and check MMA/homocysteine and consider intrinsic factor antibody testing if B12 deficiency etiology is unclear.
  • Chloride and the renal panel (BUN/creatinine/urea/uric acid) findings are not clinically concerning on their own.
I don't have the patient's age, sex, symptoms, or medication history, which would sharpen the interpretation (especially for the hematuria and B12 workup) - let me know if you can share that context.
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

"hs-CRP" AND cardiovascular risk prediction

Searching PubMed

HbA1c prediabetes progression diabetes risk

Searching the Web

hs-CRP 8.4 mg/L interpretation infection vs cardiovascular risk

Full "Outside Reference Range" Report - Consolidated Interpretation

CategoryTestValueUnitsRef. RangeFlag
Cardiac Riskhs-CRP8.4mg/L< 3High
CBCHematocrit (PCV)47.9%36.0-46.0Mildly high
MCHC29.4g/dL31.5-34.5Low
MCV102.4fL83.0-101.0Mildly high
Monocytes - Absolute0.18x10³/µL0.2-1.0Low
Platelet Count414x10³/µL150-410Mildly high
Plateletcrit (PCT)0.46%0.19-0.39High
RDW-SD47.2fL39.0-46.0High
UrineBacteriaPresent-AbsentAbnormal
Leucocyte EsterasePresent-AbsentAbnormal
BloodPresent-AbsentAbnormal
DiabetesABG (Average Blood Glucose)134mg/dL90-120High
HbA1c6.3%< 5.7High (prediabetes range)
Iron DeficiencyIron49.71µg/dL50-170Low
LipidHDL/LDL Ratio0.24Ratio> 0.40Low
LDL/HDL Ratio4.2Ratio1.5-3.5High
LDL Cholesterol177mg/dL< 100High
Non-HDL Cholesterol199mg/dL< 160High
TC/HDL Ratio5.7Ratio3-5High
Total Cholesterol241mg/dL< 200High
LiverSerum Globulin3.87gm/dL2.5-3.4High
RenalCreatinine0.51mg/dL0.55-1.02Low
Vitamins25-OH Vitamin D24.8ng/mL30-100Insufficient
Vitamin B12132pg/mL197-771Deficient

Interpretation by system

1. Likely active urinary tract infection driving several other findings. The urine triad of bacteria + leukocyte esterase + blood present is classic for a UTI - leukocyte esterase reflects pyuria (white cells in urine, ~87-88% specific for infection), and combined with bacteria this strongly suggests cystitis or pyelonephritis rather than an isolated finding - Campbell-Walsh Urology, Tintinalli's Emergency Medicine. This matters because it likely explains two other "abnormal" results:
  • hs-CRP of 8.4 mg/L falls in a gray zone: above the cardiovascular-risk cutoff (>3 mg/L) but below the >10 mg/L threshold that typically signals acute infection/inflammation rather than baseline cardiovascular risk. Given the concurrent UTI, this CRP elevation is more likely driven by active infection than by underlying atherosclerotic risk. hs-CRP should be re-checked after the infection resolves before using it for cardiovascular risk stratification - Medscape, Braunwald's Heart Disease ("hsCRP is not recommended in routine risk assessment" during acute states).
  • Elevated serum globulin (3.87) and mild reactive thrombocytosis (platelet count 414, plateletcrit 0.46) are also consistent with an active inflammatory/infectious process - acute infections raise acute-phase globulins, and reactive thrombocytosis is a recognized response to systemic inflammation or infection (as well as iron deficiency, both present here) - Henry's Clinical Diagnosis and Management, Washington Manual of Medical Therapeutics.
2. Mixed/dimorphic anemia picture - iron deficiency plus B12 deficiency. This is the most interesting hematologic finding: MCV is elevated (102.4, macrocytic) while MCHC is low (29.4, hypochromic) and RDW is markedly elevated (47.2, indicating high variability in red cell size). This combination - a high RDW with an average MCV that looks only mildly abnormal - classically occurs when two opposing anemias coexist: iron deficiency (which produces small, hypochromic cells) and B12 deficiency (which produces large, macrocytic cells). The two populations average out toward a near-normal or mildly elevated MCV, but the RDW rises sharply because the cell sizes are actually very heterogeneous - Henry's Clinical Diagnosis and Management, Washington Manual of Medical Therapeutics. This fits directly with your labs: iron is low (49.71, at the bottom of range) and B12 is significantly deficient (132 pg/mL). A peripheral smear (looking for both microcytic/hypochromic cells and macro-ovalocytes/hypersegmented neutrophils together) would confirm this dual picture. Reactive thrombocytosis is also a recognized companion of iron deficiency specifically - Dermatology 2-Volume Set, Quick Compendium of Clinical Pathology.
3. Dyslipidemia has worsened compared to the prior lipid panel (LDL now 177 vs. 167 previously; total cholesterol 241 vs. 236; HDL/LDL ratio down to 0.24 from 0.33). Combined with the previously noted elevated Lp(a), this patient's overall atherogenic burden is significant and trending in the wrong direction - warrants closer lipid management and cardiology follow-up as discussed before.
4. Prediabetes. HbA1c of 6.3% falls squarely in the ADA-defined prediabetes range (5.7-6.4%), and average blood glucose (134 mg/dL, estimated from HbA1c/CGM) is also above the optimal range - Harrison's Principles of Internal Medicine, Tietz Textbook of Laboratory Medicine. Recent meta-analyses show this stage carries a real (10-50% annual) risk of progression to type 2 diabetes depending on risk factors present, and is a good point to intervene with lifestyle changes (weight, diet, activity) - PMID 40165126, 2025 systematic review.
5. Vitamin D insufficiency (24.8 ng/mL) - milder than the deficiency seen in the earlier report, but still below optimal (30-100 ng/mL) and worth supplementing.
6. Vitamin B12 deficiency (132 pg/mL) confirmed again, more severe here, and directly explains the anemia/RDW findings above. This needs replacement (oral high-dose or IM depending on cause/severity) and a work-up for the underlying cause (dietary, pernicious anemia, malabsorption) - current systematic reviews support both routes as effective (PMID 38231320).
7. Creatinine low (0.51) - consistent with the benign low-muscle-mass/low-protein-intake pattern discussed previously; not concerning on its own.

Suggested next steps

  • Treat the UTI (urine culture to confirm organism and guide antibiotic choice) and recheck hs-CRP, globulin, and platelet count after treatment to see if they normalize - this will clarify how much of today's inflammatory picture is infection versus baseline risk.
  • Iron studies (ferritin, TIBC, transferrin saturation) to confirm and characterize the iron deficiency, and peripheral smear + reticulocyte count to evaluate the mixed anemia pattern.
  • B12/iron replacement, followed by repeat CBC in 6-8 weeks to confirm correction of RDW/MCV/MCHC abnormalities.
  • Lipid and Lp(a) management - given the worsening trend, discuss statin intensification or additional lipid-lowering therapy with a cardiologist.
  • Prediabetes counseling - lifestyle modification now, with repeat HbA1c in 3-6 months.
  • Vitamin D supplementation.
As before, I don't have this patient's age, sex, symptoms (e.g., dysuria, fatigue, fever), or medication history - that context would sharpen the interpretation, particularly around the UTI severity and anemia etiology.

What food should be avoided

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

dietary pattern LDL cholesterol lowering

Searching the Web

foods to avoid high cholesterol prediabetes iron deficiency vitamin B12 deficiency diet

Based on the lab abnormalities across your reports (elevated LDL/total cholesterol/Lp(a), prediabetes, iron deficiency, B12 deficiency, and a likely active UTI), here's what to avoid, organized by condition:

For high cholesterol / LDL / Lp(a) (LDL 167-177, TC 236-241, elevated Lp(a))

  • Saturated fats: fatty red meat, processed meats (sausage, bacon, salami), full-fat dairy (butter, ghee, cream, full-fat cheese), palm oil, coconut oil. Dietary saturated and trans fat directly raise circulating LDL cholesterol - Goldman-Cecil Medicine, Basic Medical Biochemistry.
  • Trans fats: fried fast food, packaged baked goods, margarine, anything listing "partially hydrogenated oil."
  • Organ meats (liver, kidney) - high in dietary cholesterol.
  • A recent meta-analysis of RCTs confirms that raising the dietary polyunsaturated-to-saturated fat ratio (i.e., swapping saturated fats for unsaturated oils like olive, canola, or sunflower oil) meaningfully lowers LDL response (Hart et al. 2025, PMID 40885400).
  • Note: Lp(a) itself does not respond to diet or statins - it's genetically determined - so diet changes here are really targeting your LDL/total cholesterol, not the Lp(a) itself.

For prediabetes (HbA1c 6.3%, average glucose 134)

  • Sugar-sweetened drinks: soda, sweetened tea/coffee, energy drinks, fruit juice.
  • Refined carbohydrates: white bread, white rice, pastries, cookies, sugary cereals.
  • Dried fruit and candy (concentrated sugar with little fiber to buffer the glucose spike).
  • Favor whole grains, legumes, non-starchy vegetables, and lean protein instead - the DASH/Mediterranean pattern has evidence for improving both glucose and lipid markers together (Bonekamp et al. 2024, PMID 38331867).

For iron deficiency (iron 49.7-55, at/below lower limit)

  • Don't avoid foods outright, but avoid drinking tea or coffee with meals or right after taking iron-rich foods/supplements - tannins in tea and polyphenols in coffee are potent inhibitors of iron absorption - Harrison's Principles of Internal Medicine, Creasy & Resnik's Maternal-Fetal Medicine.
  • Calcium-rich foods/supplements and milk taken at the same time as iron-rich meals also blunt absorption - space them at least 1-2 hours apart - Harper's Illustrated Biochemistry, Goldman-Cecil Medicine.
  • High-phytate foods (bran, whole grains) in large amounts at the same meal can also reduce iron absorption, though they're otherwise healthy and shouldn't be eliminated - just don't rely on them as your only source of iron.
  • Pair iron-rich foods (meat, leafy greens, legumes) with vitamin C (citrus, tomato, bell pepper) instead, which enhances absorption.

For vitamin B12 deficiency (132 pg/mL)

  • This is a deficiency to correct, not a food to avoid. B12 only comes from animal sources (meat, fish, eggs, dairy), so if your diet is vegetarian/vegan, that's the likely driver and you'll need fortified foods or supplementation rather than "avoidance."

For the likely active urinary tract infection

  • Bladder irritants: caffeine (coffee, tea, energy drinks), alcohol, carbonated drinks, and spicy or highly acidic foods (citrus, tomato-based) can worsen urgency/frequency while the infection is active - Campbell-Walsh Urology.
  • Increase plain water intake instead to help flush the urinary tract.

General

  • Given the mildly high chloride and reactive inflammatory picture, keep sodium and heavily processed/salted foods moderate as a general cardiovascular precaution, though this wasn't flagged as a primary concern.
If you can tell me which of these conditions is the priority right now (e.g., managing cholesterol vs. treating the infection vs. correcting the anemia), I can narrow this into a simpler day-to-day meal guide.
This is a shared conversation. Sign in to Orris to start your own chat.